Nasus Pharma collaborates with Aptar to support development and commercialization of NS002: Tel Aviv Saturday, October 11, 2025, 12:00 Hrs [IST] Nasus Pharma Ltd, a clinical-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback